Treg/Th17 imbalance is associated with cardiovascular complications in uremic patients undergoing maintenance hemodialysis

Chen,Danyan; Huang,Xiaolong; Lu,Song; Gan,Hua; Tang,Weixue; Liu,Ke

doi:10.3892/br.2013.63

May-June 2013 Volume 1 Issue 3

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

May-June 2013 Volume 1 Issue 3

Full Size Image

Article

Treg/Th17 imbalance is associated with cardiovascular complications in uremic patients undergoing maintenance hemodialysis

Authors:
- Danyan Chen
- Xiaolong Huang
- Song Lu
- Hua Gan
- Weixue Tang
- Ke Liu
View Affiliations / Copyright

Affiliations: Department of Endocrinology and Nephrology, The Chongqing Zhongshan Hospital, Chongqing 400013, P.R. China, Department of Neurosurgery, No. 324 Hospital of PLA, Chongqing 400028, P.R. China, Department of Nephrology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, P.R. China, Department of Pathophysiology, Basic Medical College, Chongqing Medical University, Chongqing 400016, P.R. China
Pages: 413-419
|
Published online on: January 31, 2013

https://doi.org/10.3892/br.2013.63
Expand metrics +

Abstract

Investigations of Treg/Th17 imbalance associated with cardiovascular complications in hemodialysis are limited. The aim of this study was to examine the association between Treg/Th17 balance and cardiovascular comorbidity in maintenance hemodialysis (MHD). Uremic patients included in the present study were divided into three groups: the WHD group comprising 30 patients with no cardiovascular complications or maintenance hemodialysis (MHD), the MHD1 group comprising 36 patients presenting with cardiovascular complications during MHD, and the MHD2 group comprising 30 patients with a lack of cardiovascular complications during MHD. The control group comprised 20 healthy volunteers. Th17 and Treg cells were measured by fluorescence‑activated cell scanning (FACS). IL‑6 and IL‑10 levels were determined by enzyme‑linked immunosorbent assay (ELISA). Monocyte surface expression of the costimulatory molecules CD80 and CD86 was assessed by FACS after the monocytes were cocultured with Th17 or Treg cells in the presence or absence of IL‑17. Results revealed that the percentage of Th17 of total CD4(+) cells was significantly higher in the MHD1 (36.27±9.62% in) and WHD (35.98±8.85%) groups compared with the MHD2 (19.64±5.97%) and healthy (1.12±1.52%) groups. Elevated IL‑6 levels were obtained in Th17 cells for the MHD1 and WHD groups, whereas a marked decrease was evident when IL‑17 was blocked. However, no significant differences or cardiovascular complications were detected in the expression of CD80 and CD86 in the MHD group, whereas the expression of the uremic subgroups was statistically higher compared with the healthy controls. To the best of our knowledge, this is the first study to demonstrate that the Treg/Th17 imbalance may be associated with the pathogenesis of cardiovascular complications in uremic patients undergoing hemodialysis through the B7‑independent upregulation of IL‑6 induced by IL‑17.

View Figures

View References

1	Carrero JJ, de Jager DJ, Verduijn M, et al: Cardiovascular and noncardiovascular mortality among men and women starting dialysis. Clin J Am Soc Nephrol. 6:1722–1730. 2011. View Article : Google Scholar : PubMed/NCBI
2	House AA and Ronco C: The burden of cardiovascular risk in chronic kidney disease and dialysis patients (cardiorenal syndrome type 4). Contrib Nephrol. 171:50–56. 2011. View Article : Google Scholar : PubMed/NCBI
3	Liebman SE, Lamontagne SP, Huang LS, et al: Smoking in dialysis patients: a systematic review and meta-analysis of mortality and cardiovascular morbidity. Am J Kidney Dis. 58:257–265. 2011. View Article : Google Scholar : PubMed/NCBI
4	Dheir H, Ozkahya M, Kircelli F, et al: Glycosylated hemoglobin levels are associated with cardiovascular events in nondiabetic peritoneal dialysis patients. J Nephrol. 25:107–112. 2012. View Article : Google Scholar
5	Singh AK, Singh V, Pal Singh M, et al: Effect of immunosenescence on the induction of cardiovascular disease pathogenesis: role of peripheral blood mononuclear cells. Immunopharmacol Immunotoxicol. 30:411–423. 2008. View Article : Google Scholar : PubMed/NCBI
6	Bacharaki D, Thodis E, Passadakis P, et al: Comparative in vitro study of different peritoneal dialysis solutions on cytokine production by peripheral blood mononuclear cells. Nephron Clin Pract. 113:c321–c329. 2009. View Article : Google Scholar : PubMed/NCBI
7	Zhang J, Hua G, Zhang X, et al: Regulatory T cells/T-helper cell 17 functional imbalance in uraemic patients on maintenance haemodialysis: a pivotal link between microinflammation and adverse cardiovascular events. Nephrology. 15:33–41. 2010. View Article : Google Scholar
8	Ohkusu-Tsukada K, Toda M, Udono H, et al: Targeted inhibition of IL-10-secreting CD25⁻ Treg via p38 MAPK suppression in cancer immunotherapy. Eur J Immunol. 40:1011–1021. 2010.PubMed/NCBI
9	Korn T, Mitsdoerffer M, Croxford AL, et al: IL-6 controls Th17 immunity in vivo by inhibiting the conversion of conventional T cells into Foxp3⁺ regulatory T cells. Proc Natl Acad Sci USA. 105:18460–18465. 2008. View Article : Google Scholar : PubMed/NCBI
10	Xu L, Kitani A, Fuss I and Strober W: Cutting edge: regulatory T cells induce CD4⁺CD25⁻Foxp3⁻ T cells or are self-induced to become Th17 cells in the absence of exogenous TGF-beta. J Immunol. 178:6725–6729. 2007.PubMed/NCBI
11	Walker LS: CD4⁺ CD25⁺ Treg: divide and rule? Immunology. 111:129–137. 2004.
12	Weaver CT and Hatton RD: Interplay between the TH17 and TReg cell lineages: a (co-)evolutionary perspective. Nat Rev Immunol. 9:883–889. 2009. View Article : Google Scholar : PubMed/NCBI
13	Chen D, Huang X, Yang M, et al: Treg/Th17 functional disequilibrium in Chinese uremia on hemodialysis: a link between calcification and cardiovascular disease. Ren Fail. 34:697–702. 2012. View Article : Google Scholar : PubMed/NCBI
14	Haas J, Fritzsching B, Trübswetter P, et al: Prevalence of newly generated naive regulatory T cells (Treg) is critical for Treg suppressive function and determines Treg dysfunction in multiple sclerosis. J Immunol. 79:1322–1330. 2007. View Article : Google Scholar : PubMed/NCBI
15	Yamagiwa T, Fukunishi S, Tachibana T, et al: Abrogation of Treg function deteriorates rheumatoid arthritis. Mod Rheumatol. 22:80–88. 2012. View Article : Google Scholar : PubMed/NCBI
16	Kimura A and Kishimoto T: IL-6: regulator of Treg/Th17 balance. Eur J Immunol. 40:1830–1835. 2010. View Article : Google Scholar : PubMed/NCBI

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

Treg/Th17 imbalance is associated with cardiovascular complications in uremic patients undergoing maintenance hemodialysis

This article is mentioned in:

Abstract

Figure 1

Related Articles